Loading
Hansoh Pharmaceutical Group Co. Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Lyu Aifeng, was filed 04 May 2026.
Insider Decl.
44
Thresholds
n/a
Buy Volume
n/a
10 ops. · all time
Sell Volume
€5M
11 ops. · all time
Who traded when
BuySaleLyu Aifeng2 buys5 sales
Sun Yuan3 sales
Since the insiders bought
- -6.7%Entry HK$36.84 · Close 21 Oct 2026 HK$34.38
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Hansoh Pharmaceutical Group Co. Ltd. Strong Buy (bullish), based on 24 analysts. Average price target: HK$48.53.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,591 of 26,289 companies
66.2
score / 100
Value39
Quality93
FCF yld3.1%
Earn yld2.8%
EV/EBITDA28.8x
ROE19%
Gross mgn90%
Net mgn37%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$33.96
Analyst consensus
24 analystsStrong buy
HK$43.06Target HK$48.53(+43%)HK$55.43
Income statement
RevenueHK$15B
Gross profitHK$13.5B90% margin
EBITDAHK$6.9B46% margin
Net incomeHK$5.6B42.0% margin
Valuation
PER (trailing)25.5x
PER (forward)29.7x
P/Book4.6x
Beta0.54
Balance sheet & cash
Market capHK$205.9B
Total debtHK$105.1M
Free Cash FlowHK$6.2B
Debt / Equity11%
Profitability & ownership
ROE19.4%
ROA9.1%
% insiders79.6%
% institutions12.8%
Last declaration on 30 June 2026
Declarations44 total
86,679 shares@ HK$3.3790.0002% mcap2.3% of flowShareXHKGHKEX:DA20260630E00154
429,000 shares@ HK$28.660.0063% mcap44.4% of flowShareXHKGHKEX:DA20260630E00151
9,631 sharesShareXHKGHKEX:DA20260630E00153
429,000 shares@ HK$36.860.0075% mcap55.6% of flowShareXHKGHKEX:DA20260430E00528
109,010 sharesShareXHKGHKEX:DA20260430E00527
Canonical exit: 27 Jul 2026 (T+90)
64,845 shares@ HK$4.5730.0001% mcap2.3% of flowShareXHKGHKEX:DA20260430E00535
27,005 sharesShareXHKGHKEX:DA20260430E00532
178,200 shares@ HK$2.840.0002% mcap3.9% of flowShareXHKGHKEX:DA20260430E00533
300,000 shares@ HK$39.69890.0056% mcap91.5% of flowShareXHKGHKEX:DA20260423E00042
24,807 sharesShareXHKGHKEX:DA20250703E00483
74,423 shares@ HK$3.3791.4% of flowShareXHKGHKEX:DA20250703E00486
143,283 shares@ HK$3.3791.1% of flowShareXHKGHKEX:DA20250703E00491
298,717 shares@ HK$29.1019.9% of flowShareXHKGHKEX:DA20250703E00489
90,750 sharesShareXHKGHKEX:DA20250430E00055
211,910 sharesShareXHKGHKEX:DA20250430E00054
Canonical exit: 27 Jul 2025 (T+90)
148,500 shares@ HK$2.842.4% of flowShareXHKGHKEX:DA20250430E00057
123,750 shares@ HK$2.601.9% of flowShareXHKGHKEX:DA20250430E00056
429,000 shares@ HK$2.842.9% of flowShareXHKGHKEX:DA20250430E00060
396,100 shares@ HK$2.602.5% of flowShareXHKGHKEX:DA20250430E00058
291,850 sharesShareXHKGHKEX:DA20240702E00531
Canonical exit: 25 Sept 2024 (T+90)
1,300,000 sharesShareXHKGHKEX:DA20240702E00530
Canonical exit: 25 Sept 2024 (T+90)
184,950 sharesShareXHKGHKEX:DA20240604E00487
82,500 shares@ HK$2.601.3% of flowShareXHKGHKEX:DA20240604E00489
40,800 shares@ HK$2.840.7% of flowShareXHKGHKEX:DA20240604E00488
206,250 shares@ HK$2.603.3% of flowShareXHKGHKEX:DA20240604E00486
25 of 44 declarations
About Hansoh Pharmaceutical Group Co. Ltd.
In Hong Kong, Hansoh Pharmaceutical Group Co. Ltd. has 44 filings from only 3 filers, and most amounts are missing: none of the 10 purchases has a known amount, and only 4 of the 11 sales do, worth EUR 5.3 million in total (median EUR 1,333,586). Purchases represent 48% of open-market trades.
The largest sales are Sun Yuan's, Director: EUR 1,726,488 on April 29, 2026 and EUR 1,376,687 on June 27, 2026. Lyu Aifeng, Director, sold EUR 1,290,484 on April 20, 2026; Lyu has 30 filings including 7 purchases and 8 sales, against 13 for Sun Yuan (3 purchases, 3 sales) and 1 for Zhong Huijuan. On June 27, 2024, 2 insiders filed purchases on the same day.
Read moreShow less
The company, valued at HKD 205.9 billion, is 79.6% held by insiders. It shows 23 filings of other kinds, a median publication delay of 5 days and filings running from June 27, 2019 to June 30, 2026; 2025 holds 10, against 1 in 2020. Over twelve months: 9 filings, 1 purchase and 5 sales.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
